Philibert D, Bouchoux F, Cerede E, Corallo F, Allaire J M
Centre de Recherches Roussel Uclaf, Romainville.
Allerg Immunol (Paris). 1993 Feb;25(2):77-81.
Flunisolide (FLU), beclomethasone dipropionate (BDP) and its pulmonary metabolites beclomethasone monopropionate (BMP) and beclomethasone (B) were studied in rat for: their relative binding affinity (RBA) for the 5 classes of steroid receptors, their in vitro glucocorticoid activity on rat thymocytes, their in vivo glucocorticoid activity by oral route. These compounds displayed a strong RBA for rat lung, thymus and liver glucocorticoid receptors (FLU > or = BMP > BDP > or = B). They were also shown to have a moderate RBA for both mineralocorticoid and progestin receptors, while being devoid of any binding to androgen and oestrogen receptors. On rat thymocytes FLU exhibited the highest glucocorticoid activity (FLU > B > or = BMP > BDP). In rat oral FLU displayed a strong glucocorticoid activity with a slight first-pass metabolism as opposed to what has been reported in human.
在大鼠中对氟尼缩松(FLU)、二丙酸倍氯米松(BDP)及其肺部代谢产物单丙酸倍氯米松(BMP)和倍氯米松(B)进行了研究,内容包括:它们对5类甾体受体的相对结合亲和力(RBA)、对大鼠胸腺细胞的体外糖皮质激素活性以及经口服途径的体内糖皮质激素活性。这些化合物对大鼠肺、胸腺和肝脏糖皮质激素受体显示出很强的RBA(氟尼缩松≥单丙酸倍氯米松>二丙酸倍氯米松≥倍氯米松)。它们对盐皮质激素和孕激素受体也显示出中等的RBA,而与雄激素和雌激素受体无任何结合。在大鼠胸腺细胞上,氟尼缩松表现出最高的糖皮质激素活性(氟尼缩松>倍氯米松≥单丙酸倍氯米松>二丙酸倍氯米松)。在大鼠体内,氟尼缩松经口服显示出很强的糖皮质激素活性,且首过代谢轻微,这与在人体中报道的情况相反。